New stroke drug shows promise in preventing worsening

NCT ID NCT05445895

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a medication called Renexin CR can help people who have had a certain type of stroke (non-cardioembolic ischemic stroke) within the last 72 hours. The goal was to see if it reduces the chance of getting worse in the hospital or having another stroke within 90 days. About 483 people took part, and the study compared Renexin CR to an active control to check both safety and effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.